Isabella Screpanti

12PUBLICATIONS
31CO-AUTHORS
Molecular targetsHaematological tumoursCancer cell biologyMechanobiologyEcohydrology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 22, 2025
MAML1 drives Notch and Hedgehog oncogenic pathways by inhibiting Itch activity in triple-negative breast cancer.

Sabrina Zema, Francesca Di Fazio, Maria Pelullo

|Sep 01, 2022
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL.

Filomena De Falco, Chiara Rompietti, Daniele Sorcini

|Oct 23, 2021
Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives.

Nadezda Zhdanovskaya, Mariarosaria Firrincieli, Sara Lazzari

|Oct 19, 2020
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response.

Maria Valeria Giuli, Giulia Diluvio, Eugenia Giuliani

Pageof 2